Hypertensive subjects with type-2 diabetes, the sympathetic nervous system, and treatment implications

AJS Coats, JM Cruickshank - International journal of cardiology, 2014 - Elsevier
Central obesity is closely linked to hypertension and type-2 diabetes (DM2) in young/middle-
age. In the elderly, systolic hypertension is a reflection of aging/stiff arteries. Diastolic …

Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance

K Masuo, H Rakugi, T Ogihara, MD Esler… - Current diabetes …, 2010 - ingentaconnect.com
Overweight and obesity is a growing “world-wide epidemic problem”. Because as many as,
two-third of the adult population and a growing number of children are overweight. The …

Impact of sex and age on metabolism, sympathetic activity, and hypertension

JK Yoo, Q Fu - The FASEB Journal, 2020 - Wiley Online Library
In this brief review, we summarize the current knowledge on the complex interplay between
metabolism, sympathetic activity and hypertension with a focus on sex differences and …

[PDF][PDF] Sympathetic nervous system and arterial hypertension: new perspectives, new data

D Hering, K Narkiewicz - Polish Heart Journal (Kardiologia …, 2013 - journals.viamedica.pl
Over the past decade, arterial hypertension has become recognised as a major killer,
accounting for the greatest proportion of global cardiovascular (CV) morbidity and mortality …

Role of vagosympathetic balance in obesity-induced hypertension

H Dabiré, M Brahimi, F Hadj-Brahim… - … des Maladies du …, 2004 - europepmc.org
A sympathetic hyperactivity is a common feature in hypertension, type 2 diabetes (T2D),
ageing and obesity-induced hypertension. This increase in sympathetic activity may lead to …

Cardiac complications in hypertension and diabetes: role of sympathetic nervous activity

T Kishi, Y Hirooka - Current Hypertension Reviews, 2013 - ingentaconnect.com
Hypertension and diabetes mellitus are closely associated, Cardiovascular complications
and organ damages are augmented in hypertensive patients with diabetes mellitus …

[HTML][HTML] Hypertension and cardiometabolic risk factors

MF Neves, A Virdis, AF Sanjuliani… - International journal of …, 2013 - ncbi.nlm.nih.gov
Despite the availability of nonpharmacological approaches and pharmacological therapies
for hypertension, blood pressure control rates are disappointing all over the world [1] …

Insulin resistance and sympathetic overactivity in women

RJ Kaaja, MK Pöyhönen-Alho - Journal of hypertension, 2006 - journals.lww.com
Insulin sensitivity decreases for the first time in females at the time of menarche. A much
more profound decrease in insulin sensitivity is observed at the end of pregnancy. This …

Sympathetic nervous system, hypertension, obesity and metabolic syndrome

G Seravalle, G Grassi - High blood pressure & cardiovascular prevention, 2016 - Springer
Experimental and clinical studies have clearly shown the role of the sympathetic nervous
system in the pathophysiology of several cardiovascular and non-cardiovascular diseases …

Treatments for hypertension in type 2 diabetes-non-pharmacological and pharmacological measurements

K Masuo - Current Hypertension Reviews, 2015 - ingentaconnect.com
Obesity, hypertension, obesity-related hypertension such as hypertension with diabetes are
growing health problems. Obesity, hypertension and diabetes are important, independent …